Sigma starts turnaround

AFTER two years of hefty losses at Sigma Pharmaceuticals, Mark Hooper is confident he can return the ailing drugs wholesaler to profitability.

Sigma can see beyond loss to better days

AFTER two years of hefty losses, Mark Hooper is confident he can make the ailing drugs wholesaler Sigma Pharmaceuticals profitable again.

Pan bungle cost tops $122m

THE cost of the federal government's botched handling of

Pan debacle yields further $67.5m payout

THE cost of the federal government's botched handling of the now-defunct complementary medicines manufacturer Pan Pharmaceuticals has topped $122.5 million following the settlement of a class action yesterday.

Fear on methadone doctor shortage

THE number of Victorians dying from drug overdoses or suicide will rise if more doctors are not recruited to treat heroin addicts and tackle a crisis in the state's methadone prescribing service, drug experts warn.

Self-restraint in world of excess

WE HAVE MET THE ENEMY Daniel Akst Scribe, 303pp, $32.95

Tablets emerge as new uni tool

A technological revolution is gathering pace in Australia's universities. Geoff Maslen reports.

tv previews

How Earth Made Us Wonders of the Solar System Nurse Jackie Hot Docs: Pray the Devil Back to Hell

Bitter pill when politicians swallow big pharma's spin

Politicians always profess great sympathy for people struggling to keep up with the cost of living but often fail to put that sympathy into practice. Economists like to divide the economy into consumers on one side and producers on the other. They believe the economy should be run for the benefit of consumers, not producers. The consumer is supposed to be king.